Effect of Permanent Atrial Fibrillation on Cognitive Function in Patients With Chronic Heart Failure

详细信息    查看全文

• 作者：Maria Coma ; BSc^a ; Maria Jesú ; s Gonzá ; lez-Moneo ; MD^b ; Cristina Enjuanes ; MD^c ; ^d ; Paula Poveda Velá ; zquez ; MD^c ; Deva Bas Espargaró ; MD^c ; Bernardo Andr&eacute ; s P&eacute ; rez ; MD^c ; Marta Tajes ; PhD^d ; Anna Garcia-Elias ; PhD^d ; Nú ; ria Farr&eacute ; MD ; PhD^c ; ^d ; Gonzalo Sá ; nchez-Benavides ; PhD^e ; Julio Martí ; -Almor ; MD ; PhD^a ; ^c ; ^d ; Josep Comin-Colet ; MD ; PhD^a ; ^c ; ^d ; Bego&ntilde ; a Benito ; MD ; PhD^c ; ^d ; ^{bbenito@pardesalutmar.cat" class="auth_mail" title="E-mail the corresponding author}
• 刊名：The American Journal of Cardiology
• 出版年：2016
• 出版时间：15 January 2016
• 年：2016
• 卷：117
• 期：2
• 页码：233-239
• 全文大小：586 K

文摘

In patients with chronic heart failure (HF), cognitive impairment (CI) is associated with poorer treatment adherence and higher readmission and mortality rates. Previous studies suggest that atrial fibrillation (AF) could impair cognitive function. This study sought to assess the association between permanent AF (permAF) and CI in patients with HF. We evaluated cognitive function in 881 patients with stable HF (73 ± 11 years, 44% women, 48% with preserved ejection fraction) using the Mini-Mental State Examination test (n = 876) and the Pfeiffer's Short Portable Mental Status Questionnaire (n = 848). CI was defined as a Mini-Mental State Examination score <24 or Short Portable Mental Status Questionnaire (errors) >2. The independent association between permAF and CI was assessed by binary logistic regression analysis. A total of 295 patients (33.5%) had CI, in 5.1% of cases moderate/severe. Patients with permAF had more frequently any degree of CI (43% vs 31%), and moderate/severe CI (8% vs 5%). In the multivariate analysis, CI was associated with permAF (odds ratio 1.54, 95% C.I. 1.05 to 2.28), an older age, female gender, diabetes mellitus, chronic kidney disease, previous stroke, New York Heart Association class III/IV, and lower systolic blood pressure. No interaction was found for AF and CI between patients with reduced and preserved ejection fraction. In conclusion, the presence of permAF is independently associated with CI in patients with HF, both with reduced and preserved ejection fraction. Given the clinical impact of CI in the HF population, active assessment of cognitive function is particularly warranted in patients with HF with permAF.